Viewing StudyNCT00001060



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00001060
Status: COMPLETED
Last Update Posted: 2013-05-06
First Post: 1999-11-02

Brief Title: A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
HIV Therapeutic Vaccine View
Vaccines Synthetic View
HIV-1 View
Acquired Immunodeficiency Syndrome View
AIDS-Related Complex View
AIDS Vaccines View